January 2019 Price Concessions/NCSO – 1st update


January 2019 Price Concessions/NCSO – 1st update

January 21, 2019

Department of Health and Social Care (DHSC) has today granted the following initial list of price concessions:

Drug Pack size Price Concession
Allopurinol 100mg tablets 28 £1.70
Allopurinol 300mg tablets 28 £3.68
Co-careldopa 25mg/100mg tablets 100 £10.69
Diamorphine 10mg powder for solution for injection ampoules 5 £16.56
Diamorphine 30mg powder for solution for injection ampoules 5 £16.52
Dosulepin 75mg tablets 28 £11.00
Furosemide 20mg tablets 28 £1.25
Furosemide 40mg tablets 28 £2.21
Ibandronic acid 50mg tablets 28 £54.22
Latanoprost 50micrograms/ml eye drops 2.5ml £7.95
Losartan 25mg tablets 28 £5.27
Losartan 50mg tablets 28 £4.50
Losartan 100mg tablets 28 £6.95
Metronidazole 200mg tablets 21 £2.70
Naproxen 500mg gastro-resistant tablets 56 £18.01
Nebivolol 2.5mg tablets 28 £15.85
Quetiapine 150mg tablets 60 £6.60
Ramipril 2.5mg tablets 28 £4.15
Ramipril 5mg tablets 28 £4.15
Risperidone 500microgram tablets 20 £2.72
Risperidone 2mg tablets 60 £21.00
Risperidone 3mg tablets 60 £24.95
Risperidone 4mg tablets 60 £31.88
Sodium valproate 200mg/5ml oral solution sugar free 300 £7.00
Sodium valproate 200mg gastro-resistant tablets 100 £6.25
Sodium valproate 500mg gastro-resistant tablets 100 £17.50
Tadalafil 5mg tablets 28 £23.71
Telmisartan 20mg tablets 28 £3.80
Telmisartan 40mg tablets 28 £6.94
Valsartan 40mg capsules 28 £4.49

No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.

PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated January 2019 Drug Tariff price.  Contractors will be alerted to further updates to the price concession list through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC.

If you have problems obtaining a Part VIII product or problems obtaining the product at the stated Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and if appropriate discuss the issue with DHSC.

Posted in: ,

More Latest News >

Wuhan Novel Coronavirus

The Medicines & Healthcare products Regulatory Agency (MHRA) has via its Central Alerting System (CAS) published an alert regarding the...